MORGAN STANLEY - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$163,291
+14.3%
77,024
+66.6%
0.00%
Q2 2023$142,826
-61.8%
46,222
-33.5%
0.00%
Q1 2023$373,776
+231.5%
69,475
+309.8%
0.00%
Q4 2022$112,744
+275.8%
16,954
+121.0%
0.00%
Q3 2022$30,000
-80.0%
7,672
-74.7%
0.00%
Q2 2022$150,000
+150.0%
30,270
+198.9%
0.00%
Q1 2022$60,000
-44.4%
10,127
+9.7%
0.00%
Q4 2021$108,000
-86.7%
9,235
-82.1%
0.00%
Q3 2021$809,000
-61.4%
51,614
-54.1%
0.00%
Q2 2021$2,098,000112,4580.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$73,923,00013.88%
RA Capital Management 11,120,973$129,226,0002.28%
Paradigm Biocapital Advisors LP 629,342$7,313,0002.09%
OUP Management Co., LLC 374,714$4,354,0001.96%
JOHNSON & JOHNSON 1,074,658$12,488,0001.42%
Sarissa Capital Management LP 707,010$8,215,0000.71%
Woodline Partners LP 1,111,123$12,911,0000.18%
Artal Group S.A. 550,000$6,391,0000.17%
Orbimed Advisors 833,333$9,683,0000.12%
Laurion Capital Management LP 857,308$9,962,0000.10%
View complete list of VOR BIOPHARMA INC shareholders